by Ariana | Jun 6, 2025 | Article
Expanded Access for Adults with Moderate to Severe Systemic Lupus Erythematosus: Anifrolumab is now listed under BC PharmaCare’s Limited Coverage drug formulary. Learn More Anifrolumab (Saphnelo) is now listed under BC PharmaCare’s Limited Coverage drug formulary,...
by Ariana | Jun 3, 2025 | Article
Belimumab Approved for Lupus Nephritis: A New Hope for Patients Learn More Belimumab for lupus nephritis in BC is now publicly funded under the BC Renal Glomerulonephritis (GN) Formulary as of May 2025. This marks a significant step forward in improving access to care...
by Ariana | Mar 28, 2025 | Article
How to Access Benlysta SC for Lupus Nephritis in Ontario Benlysta SC Now Available Under Ontario Drug Benefit Effective Date: February 28, 2025 Discover how the inclusion of Benlysta SC in the Ontario Drug Benefit Program marks a significant advancement for lupus...
by Ariana | Sep 17, 2024 | Article
What is a biologic? A biologic is a pharmaceutical drug product or vaccine manufactured in, extracted from, or synthesized from biological sources. www.canada.ca/en/health-canada/services/drugs-health-products/biologics What’s the difference between a biologic...
by Ariana | Jul 27, 2024 | Article
Remember, your lupus treatment may differ from others because the disease manifests uniquely in each person. Some lupus patients may have a variety of different specialists involved in their care, such as: Rheumatologist – Typically, lupus is treated by...
